Get the latest Science News and Discoveries

Rivaroxaban reduces first and total ischemic events in patients with peripheral artery disease

None

Get the Android app

Or read this on Eureka Alert

« No benefit to FFR-guided PCI in STEMI patients with multi-vessel disease

Heart-protecting drugs likely unnecessary for many breast cancer patients »